Cyclooxygenase-2 expression in borderline ovarian tumors

Gynecologic Oncology
G FerrandinaG Scambia

Abstract

The aim of the study was to investigate by immunohistochemistry the expression of cyclooxygenase-2 (COX-2) in a single institutional series of borderline ovarian tumors (BOT). Moreover, to perform a comparative analysis, COX-2 expression was also analyzed in benign and malignant ovarian tumors. Paraffin-embedded sections form 51 BOT, 26 benign, and 37 malignant ovarian tumors were incubated with polyclonal antiserum against COX-2. The results were calculated as the product of the percentage of the immunostained tumor cells by the relative staining score. Cases with immunostaining values of >1 were considered COX-2-positive. Thirty-four (66.7%) of fifty-one BOT were considered as COX-2-positive, and this rate was not significantly different with respect to COX-2 positivity in benign (50.0%) and in malignant (51.3%) ovarian tumors (P value = 0.23). A significantly higher percentage of COX-2 positivity was found in serous (24 of 24, 100%) with respect to mucinous (9 of 26, 34.6%) BOT (P value = 0.0001). Moreover, 7 (63.6%) of 11 endocervical-type mucinous borderline ovarian tumors were COX-2-positive with respect to only 2 of 15 (13.3%) intestinal-type mucinous BOT (P value = 0.013). The same trend was observed in benign lesions, ...Continue Reading

References

Jan 1, 1995·Obstetrical & Gynecological Survey·U ElchalalJ G Schenker
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·M TsujiiR N DuBois
Dec 24, 1997·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·M DoréJ Sirois
Jan 24, 1998·Lancet·D W CramerE R Greenberg
Mar 17, 1999·The American Journal of Surgical Pathology·R F CaduffT S Frank
Sep 2, 1999·Journal of the National Cancer Institute·R B Ness, C Cottreau
Feb 10, 2000·The American Journal of Pathology·K S ChappleM A Hull
Jun 30, 2000·The New England Journal of Medicine·G SteinbachG Kelloff
Jul 6, 2000·Virchows Archiv : an International Journal of Pathology·M Dietel, S Hauptmann
Feb 24, 2001·Histopathology·K M Feeley, M Wells
Jul 11, 2001·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·A P GarrettS C Mok
Jul 27, 2001·Virchows Archiv : an International Journal of Pathology·S Hauptmann, M Dietel
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·F O RanellettiL Lauriola
Feb 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G FerrandinaF O Ranelletti
Mar 14, 2002·The American Journal of Pathology·Carsten DenkertSteffen Hauptmann
Apr 12, 2002·The American Journal of Pathology·Gad SingerIe-Ming Shih
Aug 16, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G FerrandinaG Scambia
Sep 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·N V ChandrasekharanDaniel L Simmons
Oct 11, 2002·Proceedings of the National Academy of Sciences of the United States of America·Timothy D Warner, Jane A Mitchell
Jan 28, 2003·Cancer Genetics and Cytogenetics·Jie HuUrvashi Surti
Mar 20, 2003·Journal of the National Cancer Institute·Gad SingerIe-Ming Shih
Apr 26, 2003·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·C Rodríguez-BurfordW E Grizzle
Oct 24, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A P G CrijnsE G E de Vries

❮ Previous
Next ❯

Citations

May 17, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A YoshidaS F M Derchain
Jun 30, 2009·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Joseph Menczer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.